Filing Details
- Accession Number:
- 0001104659-22-098591
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-09-08 17:52:09
- Reporting Period:
- 2022-09-06
- Accepted Time:
- 2022-09-08 17:52:09
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1633070 | Axcella Health Inc. | AXLA | Biological Products, (No Disgnostic Substances) (2836) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1898760 | Margaret Koziel | C/O Axcella Health Inc. 840 Memorial Drive Cambridge MA 02139 | Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2022-09-06 | 547 | $2.52 | 25,562 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- Represents shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units, and does not represent a discretionary trade by the reporting person.
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $2.50 to $2.52. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.